Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine Adjunct for Refractory CSOM
NCT00956748Phase 4Withdrawn
- Sponsor
- St. Paul's Hospital
- Start
- Nov 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in chronic suppurative otitis media (CSOM), sponsored by St. Paul's Hospital. Planned start Nov 2019; status: withdrawn.
02
Drugs
acetylcysteine
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on NCT00956748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956748.